Online Program Home
My Program

Keyword Search

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: Dose-response returned 10 record(s)
Tuesday, 07/31/2018
A Bayesian Adaptive Model-Based Approach for Dose Selection in a FGF21 2nd Gen Phase 1 Study
Yuping Dong


Bridging Information Between Dose-Response Curves Across Populations in Early Phase Clinical Trials
Moreno Ursino, Inserm DR PA 6


Bridging Information Between Dose-Response Curves Across Populations in Early Phase Clinical Trials
Moreno Ursino, Inserm DR PA 6
8:45 AM

Estimation of the Dose-Response Curve in the Presence of Outcome Driven Dose Titrations
Zhuqing Liu, Eli Lilly; Yongming Qu, Eli Lilly and Company
11:20 AM

Wednesday, 08/01/2018
Assessing MCP-Mod Relative to Pairwise Comparisons and Trend Tests in Dose-Ranging Design and Analysis
Anran Wang, Merck & Co Inc; Fang Liu, Merck & Co., Inc; Sammy Yuan, Merck; Man (Mandy) Jin, Merck & Co., Inc.; Meihua Wang, Merck & Co.; Akshita Chawla, Merck & Co Inc; Pranab Kumar Mitra, Merck & Co Inc; Robin Mogg, Merck Research Laboratories


Longitudinal Parametric Dose-Response Surface Model Assisted Early Phase Study Design
Yongming Qu, Eli Lilly and Company
9:50 AM

Assessing MCP-Mod Relative to Pairwise Comparisons and Trend Tests in Dose-Ranging Design and Analysis
Anran Wang, Merck & Co Inc; Fang Liu, Merck & Co., Inc; Sammy Yuan, Merck; Man (Mandy) Jin, Merck & Co., Inc.; Meihua Wang, Merck & Co.; Akshita Chawla, Merck & Co Inc; Pranab Kumar Mitra, Merck & Co Inc; Robin Mogg, Merck Research Laboratories
9:55 AM

Dependencies in Binary Regression Data Generated by Informed Sequential Dose Allocation
Nancy Flournoy, University of Missouri; Assaf Oron, Instutue for Disease Modeling
2:25 PM

Thursday, 08/02/2018
A Simulation Study Comparing MCP-Mod and a Model-Based Approach in Phase 2a Clinical Trials
Hongtao Zhang; Alan Hartford, AbbVie Inc
10:35 AM

Individualized Adaptive Dose-Response Modeling in Multiple Myeloma: Potential to Improve Patient Care
Dean Bottino, Takeda Pharmaceuticals U.S.A.
10:55 AM